top
Search terms
Results 1 - 10 of 164 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 17
Heart

Hugo ten Cate Correspondence to Dr Hugo ten Cate, Department of Internal Medicine, Maastricht University Medical Center and Cardiovascular Research Institute (CARIM), UNS 50/box 8, Maastricht 6200MD, ...

Heart, Editorial, Hugo ten Cate

Date : 01/01/2016
Heart

Christopher J Boos1, Gregory Y H Lip2 1Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK 2Haemostasis, Thrombosis and Vascular Biology Unit, University Department of ...

Heart, Editorial, Christopher J Boos, Gregory Y H Lip

Date : 01/02/2008
Heart

Objectives To determine the accuracy of CHADS2 and CHA2DS2-VASc tools for predicting ischaemic stroke or transient ischaemic attack (TIA) and death in patients without a history of atrial ...

Heart, Coronary artery disease, L Brent Mitchell, Danielle A Southern, Diane Galbraith, William A Ghali, Merril Knudtson, Stephen B Wilton

Date : 01/10/2014
Ehjcvp

Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, Henrik Renlund, Lars Wallentin, Stefan K. James, Tomas Jernberg

Date : 01/01/2016 Item size : 280123 bytes
Ehjournal

Abstract Aims Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, ...

European Heart Journal, FASTTRACK ESC Clinical Registry, A. John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Silvia Kuhls, Martin van Eickels, Alexander G.G. Turpie

Date : 07/04/2016 Item size : 258982 bytes
Epeuropace

Methods and results The study sample comprised of 336 patients [median age 76 (interquartile range (IQR) 6782 years, 136 female] with first-ever ischaemic stroke, enroled in the Lund Stroke Register ...

Europace, Atrial fibrillation, Maria A. Baturova, Arne Lindgren, Jonas Carlson, Yuri V. Shubik, S. Bertil Olsson, Pyotr G. Platonov

Date : 01/12/2014 Item size : 198605 bytes
Ejhf

Introduction Heart failure (HF) is the second most important risk factor for severe ischaemic stroke after atrial fibrillation (AF).1 HF predisposes to stroke in a multifactorial manner, including ...

European Journal of Heart Failure, Vemmos, Kostas, Ntaios, George, Savvari, Paraskevi, Vemmou, Anastasia M., Koroboki, Eleni, Manios, Efstathios, Kounali, Anna, Lip, Gregory Y.H.

Date : 01/02/2012 Item size : 173293 bytes
Ejhf

Department of Cardiology, Thoraxcenter, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. Tel: +31 50 3611327, Fax: +31 50 3614391, ...

European Journal of Heart Failure, Van Gelder, Isabelle C., Van Veldhuisen, Dirk J., Lip, Gregory Y.H.

Date : 01/09/2013 Item size : 181762 bytes
Ejhf

Introduction Heart failure (HF) is a prothrombotic state, with increased risk of deep venous thrombosis, pulmonary embolism, stroke, and myocardial infarction (MI). [1] Benefit has been shown with ...

European Journal of Heart Failure, Hopper, Ingrid, Skiba, Marina, Krum, Henry

Date : 01/01/2013 Item size : 153113 bytes
Ehjcvp

Atrial fibrillationIschaemic strokePreventionOral anticoagulationIntroduction Atrial fibrillation (AF) is an expanding epidemic,1 and ischaemic stroke due to cardioembolism remains a trademark ...

European Heart Journal - Cardiovascular Pharmacotherapy, Current Opinion, Thure Filskov Overvad, Peter Brønnum Nielsen, Gregory Y. H. Lip

Date : 12/08/2016 Item size : 256208 bytes